Xilio Therapeutics (XLO) Non Operating Income (2021 - 2026)
Xilio Therapeutics (XLO) recorded Non Operating Income of -$2.88 million in Q2 2026, compared with -$1.48 million a year earlier.
Powered by 
Analysis
Xilio Therapeutics (XLO) Non Operating Income (2021 - 2026) Analysis & Trends
On a TTM basis, Xilio Therapeutics' Non Operating Income came in at $9.54 million as of Jun 30, 2026; for FY2025, it was $6.95 million, up 196.7% from FY2024.
- Across earlier years, Non Operating Income came in at $2.34 million in FY2024 (-14.2%), $2.73 million in FY2023 (+194.4%), $927,000 in FY2022 and -$756,000 in FY2021.
- Quarterly Non Operating Income has ranged from -$14.36 million in Q3 2025 to $22.2 million in Q4 2025 over the past five years.
- Peak year-over-year performance for Non Operating Income in the last five years was growth of 682.1% in Q1 2026, against a decline of 67.7% in Q1 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $4.58 million (Q1 2026), $22.2 million (Q4 2025) and -$14.36 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 269.00 Mn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | - |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | - |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | -73.00 Mn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 387.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | - |
| 10 | Xilio Therapeutics | 162.81 Mn | -364.86 Mn | - | -2.88 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2.88 Mn |
| Mar 31, 2026 | 4.58 Mn |
| Dec 31, 2025 | 22.20 Mn |
| Sep 30, 2025 | -14.36 Mn |
| Jun 30, 2025 | -1.48 Mn |
| Mar 31, 2025 | 586,000.00 |
| Dec 31, 2024 | 536,000.00 |
| Sep 30, 2024 | 742,000.00 |
| Jun 30, 2024 | 779,000.00 |
| Mar 31, 2024 | 284,000.00 |
| Dec 31, 2023 | 475,000.00 |
| Sep 30, 2023 | 613,000.00 |
| Jun 30, 2023 | 761,000.00 |
| Mar 31, 2023 | 880,000.00 |
| Dec 31, 2022 | 701,000.00 |
| Sep 30, 2022 | 416,000.00 |
| Jun 30, 2022 | -61,000.00 |
| Mar 31, 2022 | -129,000.00 |
| Dec 31, 2021 | -145,000.00 |
| Sep 30, 2021 | -290,000.00 |
API Access
Xilio Therapeutics Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=XLO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "XLO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=XLO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();